Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06SYN
|
|||
| Former ID |
DIB004244
|
|||
| Drug Name |
Ioflubenzamide (131I)
|
|||
| Synonyms |
Solazed; Ioflubenzamide I-131; MIP-1104; MIP-1143; MIP-1144; MIP-1145; ZK-BA; Iodine-123-Solazed; Iodine-131-Solazed; MIP-1145-[123I]; MIP-1145-[131I]; Radiolabeled benzamides (melanoma), Bayer; Radiolabeled benzamides (melanoma), Molecular Insight; Iodine-123-ZK-BA; Iodine-131-ZK-BA; Melanin-targeting radiodiagnostic (melanoma), Bayer/Molecular Insight; Melanin-targeting radiotherapeutic (melanoma), Bayer/Molecular Insight; 123I-MIP-1145; 123I-Solazed; 123I-ZK-BA
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
Bayer Schering Pharma AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H25FIN3O3
|
|||
| Canonical SMILES |
CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)NC(=O)C2=CC=C(C=C2)F)I
|
|||
| InChI |
1S/C21H25FIN3O3/c1-4-26(5-2)11-10-24-21(28)16-12-17(23)18(13-19(16)29-3)25-20(27)14-6-8-15(22)9-7-14/h6-9,12-13H,4-5,10-11H2,1-3H3,(H,24,28)(H,25,27)/i23+4
|
|||
| InChIKey |
UPRRZQGAQRAODM-AWUWEVMDSA-N
|
|||
| CAS Number |
CAS 1214283-52-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00747825) Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.